Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Cancer. 2018 Jan 16;124(7):1374–1382. doi: 10.1002/cncr.31218

Table 3.

Non-hematological Toxicities

Table 3. Non-Hematologic Toxicities (Max Grade per Patient)
Dose 0 Dose 1 Dose 2 Dose 2A
Non-hematologic Toxicity G2 G3 G4 G5 G2 G3 G4 G2 G3 G4 G2 G3 G4
Nausea GI 2 1 3 1
Diarrhea 2 1
Vomitting 1 2
Hyperglycemia Metabolic 3 1 2 3
Hypomagnesemia 1 2 2
Hypokalemia 1 2
Hyponatremia 1 2
Hypophosphatemia 1 1 2 1 1
Alkaline-Phosphate LFTs 1 1 2 1 2
AST 1 1 1
ALT 1 1 2 1 2
Bilirubin 1 1 1 1
Creatinine 1 1 1
Fever (non-neutropenic) 1 1 1 1
Fatigue 2 1 1 3 1 2 1
Dyspnea 1
Dysgeusia 1
Neuropathy 1 1
Pain (abdominal) 2 1** 1*** 2
Pain (other) 2** 2*** 1 1
Biliary Infections 1 1**** 1****
Infections (other) 1 1 1 1 2 1 2 1****
Colon Perforation 1*
*

1 patient experienced a fatal colonic perforation while on treatment

**

1 patient experienced both G2 abdominal pain and G2 bone pain

***

1 patient experienced both G3 abdominal pain and G2 non-specific pain

****

1 patient experienced G3, G4 biliary infections, and G3 cholecystitis